Medicines Management / Other Guidelines /
TypeDrawer/FileDate ModifiedSize

pdf		1st Line Emollients Reviewed 2021 13:02 08/24/2021218.1k

pdf		22 CS Upadacitinib for AS 15:30 12/21/2022150.5k

pdf		2022 CS (NICE TA274) Ranibizumab Diabetic Macular Oedema 12:30 12/23/2022139.9k

pdf		2022 CS Ciclosporin in Dry Eye 15:21 12/22/202294.7k

pdf		2023 Oct Bulletin METHYLPHENIDATE & Other ADHD Meds Shortage V3 11:54 11/01/2023268.9k

pdf		2024 CS Fluocinolone Chronic Diabetic Macular Oedema 12:13 04/09/2024134.3k

pdf		2024 CS Risankizumab in UC 14:20 09/13/2024169.7k

pdf		2024 Commissioning Statement Ritlecitinib 16:59 06/26/2024123.1k

pdf		07648 Vaccine Ordering for 2018-19 Influenza Season GPpharm 05022018 Doc 09:11 07/10/2018333.8k

pdf		Acamprosate SCG V2 1 Final Version 15:05 08/21/2023381.4k

pdf		Accessing Medicines for Adults at End of Life in the Community July 2023 12:25 08/01/2023192.1k

pdf		Acne Vulgaris Pathway 2018 09:53 02/27/2019658.8k

pdf		Actinic Keratosis Pathway Primary Care Nov 2022 15:52 12/21/2022435.8k

pdf		Adult Asthma Guideline 2022 Dorset Version 12 May 23 13:41 08/23/2023354.6k

pdf		Anti Microbial Product Information for the Treatment of Infected Critically Colonised Wounds Updated 2024 12:59 03/14/2024113.4k

pdf		Anticipatory Prescribing at the End of Life in the Community July 23 12:26 08/01/2023229.7k

jpg		Antimicrobial SB Sticker 10:31 11/16/201882.3k

pdf		Antipsychotic Monitoring and Reviews MOG 22 10:01 08/18/2022277.3k

pdf		Aripiprazole for Bipolar I in Adolescents 09:10 07/10/2018267.1k

pdf		Avatrombopag Commissioning Statement NICE TA 626 V1 15:36 07/30/2020121.6k

pdf		BASH Patient Information Sheet Verapamil for Cluster Headache 15:47 05/02/2023265.1k

pdf		BPSD Guidance Final V2 Oct 2021 13:52 04/11/2023403.3k

pdf		Benzodiazepines Support Pack Aug16 09:10 07/10/2018655.3k

pdf		Biologics Decision Aid for Psoriasis 1 Updated August 2020 09:22 09/08/2020207.8k

pdf		Biologics Decision Aid for Psoriasis 2 Updated August 2020 14:54 09/07/2020171.5k

pdf		Biologics Pathway for Axial Spondyloarthritis Oct 23 13:04 12/20/202366.4k

pdf		Botulinum Toxin Type A 15:15 09/16/2022496.9k

pdf		Botulinum Toxin Type A for Overactive Bladder 15:15 09/16/2022493.2k

pdf		Bowel Management Pathway March 24 17:09 03/07/2024162.1k

pdf		CEM CMO 2023-003 17:39 12/14/2023205.4k

pdf		COMMISSIONING STATEMENT FOR PRESCRIBING RIFAXIMIN (TARGAXAN®) 12:04 10/12/2020189.8k

pdf		COVID19 Support in the Last Weeks of Life V50 1 55486 16:47 08/16/2024185.3k

pdf		CS49930 Eczema Clinical Pathway 1 10:13 12/27/2023232.1k

pdf		CS Andexanet March 23 16:20 05/02/2023156.9k

pdf		CS Bempedoic Acid with Ezetimbe NICE TA694 15:45 04/28/2023147.4k

pdf		CS Dapagliflozin NICE TA902 July 23 14:42 08/30/2023134k

pdf		CS Ivabradine NICE TA267 15:45 04/28/2023140.7k

pdf		CS TA744 Upadacitinib in Moderate RA 10:27 12/17/2021150.3k

pdf		CS Ticagrelor NICE TA 420 & 236 15:45 04/28/2023223.6k

pdf		CS Tirzepatide for Treating Type 2 Diabetes NICE TA924 (002) 15:24 04/17/2024196.3k

pdf		CS Vedolizumab for Active Crohns Disease NICE TA352 16:09 05/02/2023206.2k

pdf		CS Vedolizumab for Active Ulcerative Colitis NICE TA342 16:05 05/02/2023147.3k

pdf		CS Budesonide for Eosinophilic Oesophagitis NICE TA708 16:14 05/02/2023144.2k

pdf		CS Dapagliflozin for Heart Failure NICE TA679 Updated July 23 14:42 08/30/2023144.4k

pdf		CS Erythropoiesis Stimulating Agents for TA 323 Jan 15 09:11 07/10/2018216.8k

pdf		CS for Tofacitinib in UC NICE TA547 (1) 15:44 05/02/2023158.4k

pdf		CS Rivaroxaban in CAD or PAD NICE TA607 15:53 04/28/2023115.9k

pdf		Calcipotriol & Betamethasone Presc Guideline Nov 2023 12:59 12/20/2023143.6k

pdf		Cannabis Oil Containing Products (unlicensed) Guidance March 21 15:18 05/10/2021105.5k

pdf		Cardiology Amiodarone A4 Leaflet June 2020 12:45 05/19/202194.9k

pdf		Cardiology COMMISSIONING STATEMENT Rivaroxaban in ACS (1) 12:48 09/16/2022177.5k

pdf		Cardiology Commissioning Statement Inclisiran 14:55 12/17/2021272.1k

pdf		Cardiology Commissioning Statement TA 599 Sodium Zirconium Cyclosilicate (1) 13:31 05/06/2022267.1k

pdf		Cardiology Working Group Statement on Metolazone Oct 21 14:55 12/17/2021121.6k

pdf		Cenobamate for Focal Onset Seizures TA753 Commissioning Statement 15:53 05/09/2022159.9k

pdf		Cerazette Guidance on Its Use OCT 09 09:11 07/10/201844.1k

pdf		Ciclosporin Eye Drops Information Leaflet 14:40 12/21/2022221.1k

pdf		Clobetasol Neomycin Nystatin Guideline 2023 12:52 12/20/2023119.9k

docx		Clozapine SCR Letter CMHT 09:56 01/20/202040.9k

pdf		Commisioning Statement for TNF A Inhibitors for Ankylosing Spondylitis and Axial Spondyloarthritis July 2021 11:12 08/24/2021174.9k

pdf		Commissioning Statement Bimekizumab for Treating Active Psoriatic Arthritis NICE TA916 12:45 12/20/2023149.5k

pdf		Commissioning Statement Biological DMARDs in Moderate RA NICE TA715 V3 17:01 07/26/2023195.2k

pdf		Commissioning Statement Empagliflozin NICE TA929 Nov 23 12:37 12/20/2023116.3k

pdf		Commissioning Statement Filgotinib NICE TA676 April 23 16:45 07/26/2023121.9k

pdf		Commissioning Statement Filgotinib for Ulcerative Colitis Jan 24 14:15 02/26/2024182.1k

pdf		Commissioning Statement Ixekizumab TA537 April 2023 14:45 07/26/2023145.1k

pdf		Commissioning Statement July 2021 Certoliz and Secukiumab for PSA 11:04 08/24/2021191.6k

pdf		Commissioning Statement Ozanimod for Ulcerative Colitis 15:36 12/21/2022156.2k

pdf		Commissioning Statement Pentosan 11:22 02/03/2020434.3k

pdf		Commissioning Statement Rimegepant For Preventing Migraine NICE TA906 14:22 10/04/2023100.4k

pdf		Commissioning Statement Romosozumab 10:01 08/18/2022181k

pdf		Commissioning Statement TA718 Ixekizumab for Axial Spondyloarthritis 14:32 10/12/2021145.5k

pdf		Commissioning Statement TA719 Secukinumab for Axial Spondyloarthritis 14:32 10/12/2021147.7k

pdf		Commissioning Statement for Apremilast for PSA July 2021 11:21 08/24/2021178.4k

pdf		Commissioning Statement for Atogepant for Preventing Migraine July 24 13:00 07/15/2024119.5k

pdf		Commissioning Statement for Baricitinib NICE TA466 April 23 16:56 07/26/2023173.7k

pdf		Commissioning Statement for Brodalumab Reviewed 2021 12:11 08/24/2021169.4k

pdf		Commissioning Statement for Daridorexant 11:28 01/16/2024153.1k

pdf		Commissioning Statement for Empagliflozin NICE TA733 Nov 23 12:39 11/24/2023168.4k

pdf		Commissioning Statement for Mirikizumab for Treating Moderately to Severely Active Ulcerative Colitis Oct 23 12:02 12/20/2023133.8k

pdf		Commissioning Statement for NICE TA345 Naloxegol and TA651 Naldemedine 12:30 02/17/2023204.1k

pdf		Commissioning Statement for PRUCALOPRIDE NICE TA211 (1) 12:30 02/17/2023149.9k

pdf		Commissioning Statement for Rimegepant for Treating Migraine 11:32 01/16/2024151.2k

pdf		Commissioning Statement for TA375 RA April 23 14:27 08/31/2023129.3k

pdf		Commissioning Statement for Tofacitinib for Treating Active Ankylosing Spondylitis Oct 23 12:18 12/20/2023125.1k

pdf		Commissioning Statement for Upadacitinib for Non Radiographic AS 15:18 04/28/2023151.5k

pdf		Commissioning Statement for Ustekinumab for Crohns NICE TA456 12:30 02/17/2023165.7k

pdf		Commissioning Statement for Ustekinumab for UC NICE TA633 12:30 02/17/2023236.4k

pdf		Commissioning Statement for Golimumab NICE TA497 April 23 16:08 07/26/2023165.8k

pdf		Commissioning Statement for Lebrikizumab in Dermatitis Aug24 12:09 10/03/2024165.5k

pdf		Commissioning Statement for Tofacitinib TA543 April 23 14:53 07/26/2023120.5k

pdf		Commissioning Statement for Upadacitinib NICE TA665 April 23 16:26 07/26/2023139.8k

pdf		Commissioning Statement for Ustekinumab in Active PSA NICE TA340 April 23 V3 16:49 07/26/2023145.5k

pdf		Commissioning Statement Relugolix Estradiol Norethisterone 16:35 01/10/2023161.4k

pdf		Commissioning Statement Upadacitinib for Ulcerative Colitis Jan 23 (1) 13:00 02/17/2023342.7k

pdf		Commissioning Statement Cannabis Updated Dec 20 13:00 02/09/2021210.2k

pdf		Commissioning Statement Erenumab Reviewed Feb 2023 10:59 05/31/2023126k

pdf		Commissioning Statement Finerenone May 23 Final 14:23 07/26/2023186.5k

pdf		Commissioning Statement Fluocinolone IVI 09:58 10/17/2019105.7k

pdf		Commissioning Statement Galcanezumab Reviewed Feb 2023 11:14 05/31/2023128k

pdf		Commissioning Statement Liraglutide Saxenda Weight Management Dec 2020 13:00 02/09/2021130.3k

pdf		Commissioning Statement PCSK9 July 2021 15:00 08/20/2021175.5k

pdf		Commissioning Statement for Bimekizumab for Treating Axial Spondyloarthritis NICE TA918 12:32 12/20/2023133k

pdf		Commissioning Statement for IQoro Feb 23 14:55 04/28/202391.6k

pdf		Commissioning Statement for Sarilumab July 2021 11:15 08/24/2021138k

pdf		Commissioning Statement for Avatrombopag for Primary ITP Jan 23 12:30 02/17/2023137.8k

pdf		Commissioning Statement for Biosimilar May 2023 12:52 06/30/2023132.7k

pdf		Commissioning Statement for Infliximab, Adalimumab and Golimumab NICE TA329 (1) 12:30 02/17/2023248.4k

pdf		Community Pharmacy Palliative Care Drugs List Final 23 11:50 02/28/2024130.2k

pdf		Continence DCHS off Formulary Form 09:11 07/10/201824.3k

pdf		Covid Palliative Care Service Claims Pack April2020 14:46 08/16/2024186.7k

pdf		Criteria Based Access Protocol Botulinum Toxin Type A 09:11 07/10/2018496.9k

pdf		DCCG Labetalol Shortage Final 120419 16:14 04/12/2019341.8k

pdf		DFU SOC Pathway Dorset Leaflet Updated Feb 2024 12:59 03/14/2024289.8k

pdf		DMAG Annual Report 2022-2023 14:06 07/27/2023439.3k

pdf		DMAG Summary Jan 23 14:29 02/21/2023296.2k

pdf		DMAG Summary July 2023 16:36 08/30/2023183.1k

pdf		DMAG Summary March 2023 15:21 05/03/2023254.7k

pdf		DMAG Summary May 2023 (1) 14:06 07/27/2023242.3k

pdf		DMAG Summary November 23 10:29 12/27/2023223.3k

pdf		DMAG Summary September 2023 10:53 11/02/2023163.6k

pdf		Dapagliflozin for CKD Commissioning Statement March 2022 DMAG Final 16:53 06/15/2022165.4k

pdf		Degarelix Commissioning Statement 09:11 07/10/2018198.7k

pdf		Deprescribing Bisphosphonates 14:50 12/21/2022234.5k

pdf		Derm 2023 CS Pigmanorm 14:18 03/28/202394.1k

pdf		Dermatology CS Apremilast in Moderate Severe Plaque Psoriasis 16:01 12/22/2022158.1k

pdf		Dermatology CS Baricitinib for Dermatitis April 23 12:01 07/20/2023196.1k

pdf		Dermatology CS Certolizumab TA574 Psoriasis 16:08 12/22/2022122k

pdf		Dermatology CS Dundee Sunscreen 2022 09:54 03/30/2023190.7k

pdf		Dermatology CS Dupilumab Moderate Severe Atopic Dermatitis 15:55 12/22/2022151.8k

pdf		Dermatology CS Ixekizumab Moderate Severe Plaque Psoriasis (2) 16:13 12/22/2022119.5k

pdf		Dermatology CS Omalizumab in Chronic Spontaneous Urticaria 15:34 12/22/2022117.5k

pdf		Dermatology CS Risankizumab Moderate Severe Plaque Psoriasis (1) 15:41 12/22/2022118.8k

pdf		Dermatology CS Secukinumab in Moderate Severe Plaque Psoriasis 15:50 12/22/2022144.3k

pdf		Dermatology CS for Bimekizumab for Plaque Psoriasis April 23 12:58 07/20/2023161.6k

pdf		Dermatology CS Tildrakizumab for Plaque Psoriasis April 23 (1) 12:18 07/20/2023123.4k

pdf		Diabetes Appendix 3 Draft Guidance for Insulin Start in Type 2 Diabetes 14:25 12/14/2020130.2k

pdf		Diabetes Appendix 4 Draft Growth Hormone in Children and Adults Commissioning Statement Vs Edits (002) 14:25 12/14/2020156.6k

pdf		Diabetes CGM FAQs V 2 1 Sept 23 10:44 10/23/2023164.7k

pdf		Diabetes GLP 1s Commissioning Statement Nov 2021 15:09 12/16/2021145.6k

pdf		Diabetes Local Guidance for the Safe Use of SGLT2i (1) 14:47 04/28/2023305.2k

pdf		Diabetes Foot Wound Care Formulary and Anti Microbial Management Updated February 2024 12:59 03/14/2024231.3k

pdf		Dorset Asthma Prescribing Guide for CYP Final V 2 May 23 13:41 08/23/2023376.7k

pdf		Dorset Biologics Pathway for Psoriatic Arthritis Oct 23 16:44 12/19/2023103.3k

pdf		Dorset Bowel Continence Formulary 5th Edition Booklet for Printing Mar24 17:09 03/07/20241.1M

pdf		Dorset Bowel Continence Formulary 5th Edition March25 17:09 03/07/20241.1M

pdf		Dorset COPD Guideline 2022 V4 Post DMAG Additions (002) 15:54 12/21/2022435k

pdf		Dorset Green Inhaler Guidance DMAG Version V2 (2) 14:52 09/16/20221M

pdf		Dorset Guideline for Replacement of Iron in Iron Deficiency Anaemia 2024 (1) 14:35 07/30/2024249.3k

pdf		Dorset Insulin Formulary for Type 1 Type 2 Diabetes in Adults Nov 23 16:13 01/04/2024137.5k

pdf		Dorset Medicines Governance Pathway Aug 24 10:54 08/19/2024148.3k

pdf		Dorset Opioid Resource Pack FINAL Sept 2020 08:50 09/17/20201.6M

pdf		Dorset Pathway for Bisphosphonates in Post Menopausal Women 09:11 07/10/2018326.5k

pdf		Dorset Shared Care Guideline Alkindi May 24 08:33 05/22/2024372.4k

pdf		Dorset Shared Care Guideline Sustanon May 24 11:07 05/20/2024381.5k

docx		Dorset Shared Care Guideline TEMPLATE Jan 23 (1) 12:23 03/21/202360.3k

pdf		Dorset Vitamin and Mineral Supplementation Guidelines 2024 V2 13:56 03/28/2024189.3k

pdf		Dorset Traffic Light Categorisations May 2024 10:27 07/01/2024221k

pdf		Dorset Version SCP Amiodarone for Patients Within Adult Services (2) 11:49 05/17/2023383.3k

pdf		Dorset Version SCP Dronedarone for Patients in Adult Services (3) 11:49 05/17/2023390.2k

pdf		Dry Eye Prescribing Guidelines 09:09 05/04/2020240.2k

pdf		ENC 57g IN USE EXPIRY OF EYE DROPS IN A SECONDARY CARE SETTING May 2019 Approved 16:29 07/31/2019253.4k

pdf		ENC D Regulation 28 Letter 15 12 17 07519 09:11 07/10/2018213.5k

pdf		EllaOne Guidance March 2010 09:11 07/10/201830k

pdf		Eltrombopag 09:11 07/10/2018281.6k

pdf		Emollient Comparison Chart 2021 12:53 08/24/2021242k

pdf		Empagliflozin for CKD Commissioning Statement March 24 16:40 03/14/2024174.3k

pdf		Etrasimod for UC Commissioning Statement March 24 12:43 04/10/2024133.9k

pdf		Evra Guideline to Support Prescribing Jan 15 09:11 07/10/2018516.9k

pdf		Eye Drop Conversion Table 09:11 07/10/2018245.5k

pdf		FWG 2022 CS (NICE TA283) Ranibizumab Macular Oedema RVO 16:36 12/22/2022120.6k

pdf		FWG 2022 CS (NICE TA298) Ranibizumab Choroidal Neovascularization 12:23 12/23/2022118k

pdf		FWG 2022 CS (NICE TA305) Aflibercept for Visual Impairment Sec to CRVO 11:03 12/23/202297.1k

pdf		FWG 2022 CS (NICE TA346) Aflibercept in Diabetic Macular Oedema 11:10 12/23/2022149.4k

pdf		FWG 2022 CS (NICE TA460) Adalimumab and Dexamethasone Implant Non Infectious Uveitis 10:48 12/23/2022186.3k

pdf		FWG 2022 CS (NICE TA486) Aflibercept for Choroidal Neovascularisation 10:51 12/23/202295.6k

pdf		FWG 2022 CS Botulinum A Xeomin 12:04 12/23/2022147.6k

pdf		FWG 2022 CS Ocriplasmin 12:18 12/23/2022120.2k

pdf		FWG CS Lusutombopag in Thrombocytopenia in Liver Disease 16:28 12/22/2022116.8k

pdf		Faricimab for DMO Commissioning Statement NICE TA 799 10:01 08/18/2022180.6k

pdf		Faricimab for Wet AMD Commissioning Statement NICE TA800 10:01 08/18/2022182.5k

pdf		Feb 2023 KTTT 09:31 03/02/2023186.4k

docx		Feedback Form Updated V2 12:24 03/16/202331.6k

pdf		Fentanyl IR Commissioning Statement 2023 15:57 12/19/2023209.3k

docx		FluOOS Community P'cy Claim NHS D V3 Review Aug 24 14:14 08/15/202323.2k

docx		FluOOS Invoice Template NHS Dorset ICS V 2 Aug23 14:14 08/15/202320.5k

docx		FluOOS PSD Proforma V3 Aug 23 14:14 08/15/202322.9k

docx		FluOOS Protocol NHS Dorset V3 Aug 23 16:02 08/15/202370.8k

pdf		Formulary Continence Desmopressin (1) 12:40 06/01/2022187.7k

pdf		Formulary Guidelines for the Prescribing of Stoma Additional Products in PC Oct 21 10:52 04/29/2022291.7k

docx		Formulary Proposal Form Jan 23 14:47 08/17/2023112.4k

pdf		Formulary Schematic Diagram Nov 21 09:26 12/16/2021106.1k

pdf		Formulary Decision Making Criteria 17:23 08/31/2021106.5k

pdf		Fortacin Comissioning Statement March 17 09:11 07/10/2018343.5k

pdf		Fremanezumab for Migraine TA764 Commissioning Statement 15:18 05/09/2022125.3k

docx		GLP 1 Agreement Form 08:10 07/23/202446.6k

pdf		GUIDANCE ON PRESCRIBING OF CONTRACEPTIVES TO GIRLS UNDER 16 YEARS 16:04 10/15/2020358k

docx		Gastroenterology Mesalazine Asacol to Octasa Patient Switch Letter 16:18 12/14/202023.9k

pdf		Great Green Respiratory Care Poster 13:36 04/03/2023110.4k

pdf		Guidance for the Management of Insomnia and Daridorexant V2 16:56 01/23/2024151.4k

pdf		Guidance on the Use of Antipsychotics for Conditions Other than Schizophrenia 09:11 07/10/201836.2k

pdf		Guideline for Eflornithine 2023 15:52 08/21/2024147.1k

pdf		IBD High Cost Drugs Pathway V5 April 24 12:43 04/10/2024303.4k

pdf		ICD AssessmentTool 09:11 07/10/2018109.1k

pdf		IL 6 Inhibitors for Patients Hospitalised Due to COVID 19 Nov 22 13:52 11/30/2022248.4k

pdf		IMOC Summary August 24 09:44 10/09/2024235.6k

pdf		IMOC Summary June 24 13:01 08/05/2024215.6k

pdf		IN 227 Dementia Pathway 2022 V2 (002) 14:54 12/21/2022168.1k

pdf		INCLISIRAN FAQ Final Version 05 05 2023 15:44 05/10/2023109.3k

pdf		In Focus Fibrates July 23 15:15 09/15/2023164.2k

pdf		In Focus Quetiapine XL Final 09:21 07/19/2018213.8k

pdf		In Focus Quinine V3 July 23 15:14 09/15/2023164.8k

pdf		In Focus PERT Jan 24 (1) 14:14 02/26/2024157.2k

pdf		Interim Commissioning Statement CGM in Type 2 Diabetes V2 09:54 08/06/202484.9k

docx		JWFG Nonformulary Rationale Form V2 16:25 03/16/202332.3k

pdf		JWFWG Dorset Skin Tear Pathway Updated February 2024 12:59 03/14/2024381.7k

pdf		JWFWG Napkin Associated Dermatitis 15:57 05/09/2022470k

pdf		JWFWG Napkin Associated Dermatitis 2024 V2 13:21 08/06/2024103.3k

pdf		JWFWG Pan Dorset Moisture Pathway 14:30 05/06/2022250.6k

pdf		JWFWG Pan Dorset Moisture Pathway 2024 V3 13:21 08/06/2024120.9k

pdf		LFPSE Comms 03 03 23 09:09 03/30/202395.6k

pdf		Leg Cramps Leaflet Sept 23 12:10 09/27/2023199.2k

docx		Letter to Hospital to Decline Prescribing May 2023 14:58 05/18/202336.1k

pdf		Liothyronine Position Statement 2024 09 30 09:11 10/08/2024113.1k

pdf		Local Shortage Guidance 12 Hour MR Methylphenidate Tablets Oct 24 24 10 24 09:32 11/01/2024460.5k

pdf		Local Shortage Guidance PERT Therapy V3 NOV 24 16:37 11/12/2024463.1k

pdf		Local Shortage Guidance Quetiapine Immediate Release 0624 14:05 06/12/2024211.7k

pdf		Local Shortage Risk Matrix 13:51 08/09/202453.7k

pdf		Management of Fibromyalgia 2017 09:11 07/10/2018721.8k

pdf		Management of Neuropathic Pain Final Aug 09 09:11 07/10/201829.4k

pdf		Management of Type 2 Diabetes Version 1 2 16 Apr2024 15:23 04/17/20241M

pdf		Management of Type 2 Diabetes Version 1 2 180724 09:21 07/18/20241000.4k

pdf		Management of Hyperhidrosis Guidance Nov 23 15:40 12/19/2023279.3k

pdf		Management of Hypomagnesaemia in Primary Care Jan 23 Copy 14:09 02/17/2023185.9k

docx		Managing Vitamin B12 Injections During COVID (002) 09:20 03/31/202041.7k

pdf		March 2023 KTTT 15:10 03/29/2023288.4k

pdf		Medicine Supply Notification Salbutamol 2 5mg in 2 5ml Nebuliser Liquid Unit Dose Vials 06032024 14:14 03/07/2024141.1k

pdf		Mental Health Discontinuation of Fluphenazine Decanoate 09:36 10/19/2018379.4k

docx		Mental Health Managing Trimipramine Final March 21 10:33 06/10/202152.3k

pdf		Mental Health Primary Care Protocols Depression Final 2018 09:11 07/10/2018255.1k

pdf		Mental Health Primary Care Protocols Anxiety FINAL 2018 09:11 07/10/2018177.1k

pdf		NHS Dorset Advice for Pc and Adhd Prescribing Following Private Diagnosis Dec 23 14:17 12/14/2023200.6k

pdf		NICE TA 358 Tolvaptan Commissioning Statement Reviewed July 21 16:09 10/12/2021115.5k

pdf		NICE TA 803 CS Risankizumab for Psoriatic Arthritis 12:49 10/18/2022131.8k

pdf		NICE TA 805 CS Icosapent Ethyl 09:43 10/12/2022164.8k

pdf		NICE TA 807 CS Roxadustat for Treating Symptomatic Anaemia in Chronic Kidney Disease 09:43 10/12/2022119k

pdf		NICE TA 814 CS for Biologics in Dermatitis 10:21 11/07/2022152.3k

pdf		NICE TA 815 CS Guselkumab for Psoriatic Arthritis 13:40 10/19/2022129.3k

pdf		NICE TA 820 CS Brolucizumab for Treating Diabetic Macular Oedema 11:32 10/17/2022237.3k

pdf		NICE Upadacitinib for Active Psoriatic Arthritis NICE TA768 Commissioning Statement 15:22 05/09/2022133.5k

doc		NOTIFICATION OF HIGH COST EXCLUDED Drugs 2018 09:30 07/19/201841k

pdf		NSAID Info Prescribers 0519 09:14 05/16/2019651.3k

pdf		Nalmefene COMMISSIONING STATEMENT Jan 2015 09:11 07/10/2018339.4k

pdf		National Hydroxycarbamide Shared Care Protocol DMAG Approved Jan 23 12:30 02/17/2023345.3k

pdf		Nebuliser Pathway Pdf V2 May 23 14:21 08/23/2023377.4k

pdf		ONS QA April 2021 14:09 10/14/2021149.4k

pdf		Omalizumab Commissioning Statement NICE TA 339 Updated 2018 09:36 10/19/2018531.2k

pdf		Opioid Substitute COMMISSIONING STATEMENT 09:11 07/10/2018358.1k

pdf		Osteoporosis Commissioning Statement Bisphosphonates TA464 May 2021 16:11 08/23/2021207.3k

pdf		Osteoporosis Denosumab Guideline Nov 21 09:38 12/10/2021204.7k

pdf		PALIPERIDONE LONG ACTING INJECTION Guidelines 2013 09:11 07/10/2018237.1k

pdf		PATHWAY FOR PRESCRIBING ORAL NUTRITIONAL SUPPLEMENTS IN DORSET ICB APRIL 23 (1) 10:49 12/07/2023250.3k

pdf		PED SS BBS1-24 Urinary Incontinence Product Booklet One Page View July 24 13:02 07/23/2024688k

pdf		PHE Guidance for Phased Re Introduction of Hepatitis B Vaccine for Lower Priority Groups 2018 09:11 07/10/2018247k

pdf		Paediatric Liquid Medicines Standardised Concentrations Sep 20 Version 1 2 11:56 12/16/2020473.9k

pdf		Pain Management Guidance 2019 13:09 09/26/20191.8M

pdf		Palforzia for Peanut Allergy NICE TA 769 Commissioning Statement 15:27 05/09/2022130.5k

pdf		Palliative Care Drug Pharmacies Updated Feb 24 14:37 02/28/2024166.5k

pdf		Palliative Covid Care Drugs Service Updated 30 04 20 14:32 08/16/2024226.9k

pdf		Pan Dorset Wound Care by Tissue Type Updated February 2024 12:59 03/14/2024107.1k

pdf		PancreaticEnzymeReplacementTherapy (A Guide to Taking) (1) 12:26 10/12/202050.5k

pdf		Parkinson's Disease Guideline Nov 20 15:09 12/14/2020314k

pdf		Pathway for Taking a Drug through the Formulary Process 17:23 08/31/202160.2k

pdf		Patiromer Commissioning Statement March 2020 13:53 04/30/2020158.4k

pdf		Phosphate Binder Shared Care Guideline Final Aug 2020 12:04 10/12/2020221.5k

pdf		Position Statement on the Prescribing of Preservative Free Eye Drops 2024 Update 09:22 07/18/202493.1k

pdf		Potassium Citrate Stopping Criteria Letter 14:37 12/21/202292.1k

pdf		Pregabalin PSL April 2022 V2 12:23 11/01/2022168.3k

pdf		Prescribable Continuous Gloucose Monitoring for Adults Children and Young People 10:11 10/17/2024415.7k

pdf		Prescribable CGM CS 26 Sep 2024 10:11 10/17/2024171.1k

pdf		Prescribing for Overseas Travel V4 1 April 2021 (1) 15:15 09/11/2024237.2k

pdf		Prescribing of Quetiapine MR and IR Formulations 09:11 07/10/2018163.7k

pdf		Primary Care Management of High INR July 2017 09:11 07/10/2018637.5k

pdf		Private Prescribing in Primary Care NHSD 16:03 02/01/2023166.5k

pdf		Protocol for Carer Sc Admin Apr 2020 16:54 08/16/2024330.7k

pdf		Proton Pump Inhibitor Deprescribing Algorithm (adults) PrescQIPP V2 September 2020 12:04 10/12/2020119.4k

pdf		Psoriasis Management in Adults 2023 16:24 12/15/2023465.6k

pdf		QTc Prolongation Guidance for Mental Health Prescribers 09:23 09/05/2019397.3k

pdf		Quick Formulary Guide Document Aug 23 15:06 08/02/2023132k

pdf		RMOC Combination Use of Biologics for Different Co Morbidities RMOC Regional Advisory Statement V1 July21 10:55 12/17/2021140.4k

pdf		Recording Medication Issued at Another Organisation 062021 15:28 07/08/2021285.8k

doc		Rep Request Form Aug 2024 15:11 08/09/2024856k

pdf		Rheumatology Dorset Biologic RA Pathway V2 Dec 2021 10:27 12/17/2021132.8k

pdf		Risks Associated with Gabapentinoids V2 March 2023 16:31 04/18/2023204.3k

pdf		Rosacea Pathway Nov 23 16:12 12/15/2023213k

pdf		SGLT2s Commissioning Statement July 2021 12:07 08/23/2021174k

pdf		SHARED CARE GUIDELINE FOR PRESCRIBING RIFAXIMIN (TARGAXAN®) 12:04 10/12/2020213.8k

pdf		SMS Nov 22 19:18 11/30/2022234.9k

pdf		SSC2338 NICE Guidance Inclisiran TA733 Update Letter 030221 (1) 10:48 02/28/2022128.7k

pdf		Safety Bulletin Dosulepin Final 2021 10:33 06/10/2021267.8k

pdf		Shared Care Guideline for Colistimethate in Non CF Bronchiectasis Nov 2020 15:35 05/10/2021157.4k

pdf		Shared Care Sativex November 2020 14:51 12/14/2020238.2k

pdf		Shared Decision Tool CGM V 2 1 29 3 2023 11:49 05/18/2023125.6k

pdf		Sick Day Rules for People with Type 2 Diabetes V1 (1) 15:24 08/30/2023167.4k

pdf		Soap Substitutes Patient Information Leaflet Nov 23 15:46 12/15/2023109k

pdf		Solriamfetol for Excessive Daytime Sleepiness TA758 Commissioning Statement 15:51 05/09/2022163k

pdf		Step by Step Guide to Using the Dorset Wound Care Products Template on SystmOne NHSD 16:03 02/01/2023512.1k

pdf		Sterile Dressing Pack Statement Final 15:00 12/22/2022147.9k

pdf		Steroid Cards In Focus June 2021 11:00 04/23/2024230.3k

pdf		Stoma In Focus Final 09:21 07/19/2018369.2k

pdf		Stopping DOACs Before Procedures August 2018 10:45 09/11/2018371.2k

pdf		Stopping Your PPI Patient Information Leaflet (2) 12:48 09/16/2022202.7k

pdf		SystmOne CGM Protocol V 2 29 03 2023 15:56 03/29/2023341.6k

pdf		T1DM Prescribable CGM Pathway 1 1 20 12 22 11:49 05/18/2023116.9k

pdf		Tacrolimus Prescribing Guidance Sep 2018 09:42 04/11/2019350.8k

pdf		Targeted Release Budesonide Commissioning Statement NICE TA937 March 24 16:53 03/14/2024170.5k

pdf		Testosterone Guideline April 22 15:12 04/25/2022131.9k

pdf		Thickener Quantities 2020 15:16 12/14/2020168k

pdf		Tips for Taking Supplements April 2021 11:20 09/05/2021113.6k

pdf		Tirzepatide and GLP1 Prescribing in SystmOne 10:47 04/04/2024186.4k

pdf		Tirzepatide and GLP1 Prescribing in SystmOne (1) 15:23 04/17/2024186.4k

pdf		Trans Anal Irrigation Pathway March24 17:09 03/07/2024821.2k

pdf		Treatment of Constipation in Adults V3 Nov 2022 12:30 02/17/2023253.9k

pdf		Type 2 Diabetes in Adults SGLT2 April 23 15:24 08/30/2023141.4k

pdf		UI Formulary June 2020 Final 10:23 08/19/2020143.9k

pdf		Understanding Urine Results PH Final NHSD 16:03 02/01/2023177.1k

pdf		Updated Commissioning Statement OPEP (flutter) Devices 2019 (1) 12:34 05/30/2023212.8k

pdf		Updated Eligibility Criteria for Antivirals and NMABs 2022 06 24 15:43 06/29/2022469.6k

pdf		Urine Dipsticks Leaflet To Dip or Not to Dip 14:18 10/23/2018566.5k

pdf		Urticaria Pathway Nov 2023 16:06 12/15/2023242k

pdf		V4 Sativex Pathway Dorset February 2021 (002) 10:22 02/03/2021165.5k

pdf		Vit D Guidelines March 2020 14:58 07/13/2020254.8k

pdf		Vitaros August 14 09:11 07/10/2018344.3k

pdf		Vortioxetine Commissioning Statement NICE TA 367 09:11 07/10/2018211.6k

pdf		Washout Periods for Biologics (psoriasis) August 2020 14:54 09/07/2020189.1k

pdf		Wessex Palliative Care Handbook 2014 13:39 09/20/20181.1M

pdf		Yasmin Prescribing Guidance Sept 2007 13:10 11/23/201839.8k

pdf		Aflibercept 09:10 07/10/2018205k

pdf		Commissioning Statement Brolucizumab Wet AMD Feb 2021 10:27 03/01/2021116.9k

pdf		Commissioning Statement for Dexamethasone in DMO 15:18 12/21/2022129.1k

pdf		Commissioning Statement for Fostamatinib for Refractory ITP 15:39 12/21/2022145.4k

pdf		Dapoxetine Commissioning Statement 09:11 07/10/2018219.5k

pdf		Ferric Maltol Guideline 13:30 04/05/2023247.8k

pdf		Final CS Risankizumab for Previously Treated Moderately to Severely Active Crohn's Disease Oct 23 14:12 10/05/2023114.2k

pdf		Final Commissioning Statement for Deucravacitinib for Plaque Psoriasis NICE TA 907 14:50 08/31/2023168.5k

pdf		Final Commissioning Statement for Somatrogon Feb 23 15:05 04/28/202391.8k

pdf		Final Commissioning Statement Upadacitinib for Crohns Disease June 23 14:52 08/30/2023129.3k

pdf		Final Commissioning Statement Eptinezumab March 23 15:00 04/28/2023111.6k

pdf		Final Dorset Migraine Treatment V1 6 March 23 09:56 05/23/2023153.6k

pdf		Kadcyla Letter 09:11 07/10/2018257.6k

pdf		Mirabegron Comissioning Statement Sept 13 09:11 07/10/2018123.6k

pdf		Omeprazole Info for Prescribers PQ0519 09:13 05/16/2019144.1k

pdf		Oral Ketamine Comissioning Statement Final May 14 09:11 07/10/2018215.6k

pdf		Outpatients Guidance 2016 10:21 06/17/2024212.8k

pdf		Traffic Light Categorisations Redrafted March 2014 Final 11:00 04/23/2024423k